The loss of astrocytic D2R in neurodegeneration, as highlighted by the current study has clinical implications for other neurological conditions which are characterised by alterations in dopamine transmission such as Parkinson’s disease (PD) and schizophrenia. This evidence concerns the gene DRD2 and schizophrenia.